Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Focused Fund median (28 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 06 Dec 2019 – 20 Aug 2026, limited by Tata Focused Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Tata Focused Fund | Nifty 500 |
|---|---|---|
| 06 Dec 2019 | ₹100.00 | ₹100.00 |
| 27 Jun 2020 | ₹85.68 | ₹88.52 |
| 17 Jan 2021 | ₹120.47 | ₹123.39 |
| 09 Aug 2021 | ₹146.91 | ₹144.11 |
| 01 Mar 2022 | ₹151.30 | ₹147.97 |
| 21 Sep 2022 | ₹161.24 | ₹158.86 |
| 14 Apr 2023 | ₹161.61 | ₹154.66 |
| 04 Nov 2023 | ₹188.10 | ₹175.82 |
| 26 May 2024 | ₹233.65 | ₹222.18 |
| 16 Dec 2024 | ₹265.96 | ₹241.51 |
| 08 Jul 2025 | ₹257.64 | ₹243.79 |
| 28 Jan 2026 | ₹254.49 | ₹238.71 |
| 20 Aug 2026 | ₹257.87 | ₹243.17 |
| Metric | Tata · Direct NAV ₹25.76 Very High risk ★★★☆☆ | Category median Focused Fund · 28 funds |
|---|---|---|
| -0.74% | +5.84% | |
| +11.89% | +15.09% | |
| +11.88% | +13.35% | |
| — | +13.62% | |
| +15.18% | +15.49% | |
| +10.37% | — | |
| +19.53% | +16.73% | |
| +19.04% | +16.52% | |
| — | +16.05% | |
| Risk | ||
| 14.64% | 14.55% | |
| 0.37 | 0.57 | |
| 0.50 | 0.79 | |
| -37.28% | -34.05% | |
| Nifty 500 | — | |
| +0.51% | +3.16% | |
| 0.91 | 0.94 | |
| 89.7% | 104.9% | |
| 81.8% | 89.6% | |
| 0.89% | 1.06% | |
| ₹1,714Cr | ₹2,441Cr | |
| Up to 0.50% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 18% | 32% | |
| Anand Sharma · 0.9y | — | |
| 06 Dec 2019 | — | |
| 27 | — | |
| 50.0% | — | |
| 6.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.